Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 352

1.

Lower Total and Regional Grey Matter Brain Volumes in Youth with Perinatally-Acquired HIV Infection: Associations with HIV Disease Severity, Substance Use, and Cognition.

Paula Lewis-De Los Angeles C, Williams PL, Huo Y, Wang SD, Uban KA, Herting MM, Malee K, Yogev R, Csernansky JG, Nichols S, Van Dyke RB, Sowell ER, Wang L; Pediatric HIV/AIDS Cohort Study (PHACS) and the Pediatric Imaging, Neurocognition, and Genetics (PING) Study..

Brain Behav Immun. 2017 Jan 9. pii: S0889-1591(17)30003-X. doi: 10.1016/j.bbi.2017.01.004. [Epub ahead of print]

PMID:
28089557
2.

Dalbavancin Pharmacokinetics and Safety in Children 3 Months to 11 Years of Age.

Gonzalez D, Bradley JS, Blumer J, Yogev R, Watt KM, James LP, Palazzi DL, Bhatt-Mehta V, Sullivan JE, Zhang L, Murphy J, Ussery XT, Puttagunta S, Dunne MW, Cohen-Wolkowiez M.

Pediatr Infect Dis J. 2017 Jan 3. doi: 10.1097/INF.0000000000001538. [Epub ahead of print]

PMID:
28060045
3.

Cord Blood Acute Phase Reactants Predict Early Onset Neonatal Sepsis in Preterm Infants.

Mithal LB, Palac HL, Yogev R, Ernst LM, Mestan KK.

PLoS One. 2017 Jan 3;12(1):e0168677. doi: 10.1371/journal.pone.0168677.

4.

Deformed Subcortical Structures Are Related to Past HIV Disease Severity in Youth With Perinatally Acquired HIV Infection.

Lewis-de Los Angeles CP, Alpert KI, Williams PL, Malee K, Huo Y, Csernansky JG, Yogev R, Van Dyke RB, Sowell ER, Wang L; Pediatric HIV/AIDS Cohort Study (PHACS)..

J Pediatric Infect Dis Soc. 2016 Dec;5(suppl 1):S6-S14.

PMID:
27856671
5.

Prevalence of periodontal diseases in a multicenter cohort of perinatally HIV-infected and HIV-exposed and uninfected youth.

Ryder MI, Yao TJ, Russell JS, Moscicki AB, Shiboski CH; Pediatric HIV/AIDS Cohort Study..

J Clin Periodontol. 2017 Jan;44(1):2-12. doi: 10.1111/jcpe.12646.

PMID:
27801947
6.

Pharmacokinetics of Unboosted Atazanavir in Treatment-experienced HIV-infected Children, Adolescents and Young Adults.

Cressey TR, Hazra R, Wiznia A, Foca M, Jean-Philippe P, Graham B, King JR, Britto P, Carey VJ, Acosta EP, Yogev R; IMPAACT P1058A Team..

Pediatr Infect Dis J. 2016 Dec;35(12):1333-1335.

PMID:
27583590
7.

Sexually Transmitted Infections in Youth With Controlled and Uncontrolled Human Immunodeficiency Virus Infection.

Camacho-Gonzalez AF, Chernoff MC, Williams PL, Chahroudi A, Oleske JM, Traite S, Chakraborty R, Purswani MU, Abzug MJ; International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1074 Study Team..

J Pediatric Infect Dis Soc. 2016 Jul 20. pii: piw039. [Epub ahead of print]

PMID:
27440505
8.

Pharmacokinetics of Once-Daily Darunavir/Ritonavir With and Without Etravirine in Human Immunodeficiency Virus-Infected Children, Adolescents, and Young Adults.

Larson KB, Cressey TR, Yogev R, Wiznia A, Hazra R, Jean-Philippe P, Graham B, Gonzalez A, Britto P, Carey VJ, Acosta EP; International Maternal Pediatric and Adolescent AIDS Clinical Trial Protocol P1058A Team..

J Pediatric Infect Dis Soc. 2016 Jun;5(2):131-7. doi: 10.1093/jpids/piu142.

PMID:
27199469
9.

Rilpivirine Pharmacokinetics Without and With Darunavir/Ritonavir Once Daily in Adolescents and Young Adults.

Foca M, Yogev R, Wiznia A, Hazra R, Jean-Philippe P, Graham B, Britto P, Carey VJ, King J, Acosta EP, Cressey TR; IMPAACT P1058A Team..

Pediatr Infect Dis J. 2016 Sep;35(9):e271-4. doi: 10.1097/INF.0000000000001214.

PMID:
27187753
10.

Viral Bronchiolitis in Children.

DeVincenzo JP, Krilov LR, Yogev R.

N Engl J Med. 2016 May 5;374(18):1791. doi: 10.1056/NEJMc1601509#SA1. No abstract available.

PMID:
27144865
11.

Pharmacokinetics of Darunavir/Ritonavir With Etravirine Both Twice Daily in Human Immunodeficiency Virus-Infected Adolescents and Young Adults.

Cressey TR, Yogev R, Wiznia A, Hazra R, Jean-Philippe P, Graham B, Gonzalez A, Britto P, Carey VJ, Fletcher CV, Acosta EP; IMPAACT P1058A Team..

J Pediatric Infect Dis Soc. 2016 Apr 21. pii: piw017. [Epub ahead of print]

PMID:
27103489
12.

Antiretroviral Drug Resistance Among Children and Youth in the United States With Perinatal HIV.

Van Dyke RB, Patel K, Kagan RM, Karalius B, Traite S, Meyer WA 3rd, Tassiopoulos KK, Seage GR 3rd, Seybolt LM, Burchett S, Hazra R; Pediatric HIV/AIDS Cohort Study (PHACS)..

Clin Infect Dis. 2016 Jul 1;63(1):133-7. doi: 10.1093/cid/ciw213.

PMID:
27056398
13.

Computerized vital signs analysis and late onset infections in extremely low gestational age infants.

Mithal LB, Yogev R, Palac H, Gur I, Mestan KK.

J Perinat Med. 2016 Jul 1;44(5):491-7. doi: 10.1515/jpm-2015-0362.

PMID:
26845716
14.

Antiretroviral Therapy for Nevirapine-Exposed Children With HIV Infection.

Yogev R.

JAMA. 2015 Nov 3;314(17):1801-2. doi: 10.1001/jama.2015.13763. No abstract available.

PMID:
26529157
15.

Prevalence and Persistence of Varicella Antibodies in Previously Immunized Children and Youth With Perinatal HIV-1 Infection.

Purswani MU, Karalius B, Yao TJ, Schmid DS, Burchett SK, Siberry GK, Patel K, Van Dyke RB, Yogev R; Pediatric HIV/AIDS Cohort Study PHACS..

Clin Infect Dis. 2016 Jan 1;62(1):106-14. doi: 10.1093/cid/civ734.

16.

Default Mode Connectivity in Youth With Perinatally Acquired HIV.

Herting MM, Uban KA, Williams PL, Gautam P, Huo Y, Malee K, Yogev R, Csernansky J, Wang L, Nichols S, Van Dyke R, Sowell ER.

Medicine (Baltimore). 2015 Sep;94(37):e1417. doi: 10.1097/MD.0000000000001417.

17.

Executive Functioning in Children and Adolescents With Perinatal HIV Infection.

Nichols SL, Brummel SS, Smith RA, Garvie PA, Hunter SJ, Malee KM, Kammerer BL, Wilkins ML, Rutstein R, Tassiopoulos K, Chernoff MC, Mellins CA; Pediatric HIVAIDS Cohort Study..

Pediatr Infect Dis J. 2015 Sep;34(9):969-75. doi: 10.1097/INF.0000000000000809.

18.

Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.

Coelingh K, Olajide IR, MacDonald P, Yogev R.

Expert Rev Vaccines. 2015;14(10):1331-46. doi: 10.1586/14760584.2015.1078732. Review.

PMID:
26372891
19.

HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.

Harrison L, Melvin A, Fiscus S, Saidi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, McKinney R, Gibb D, Tudor-Williams G; PENPACT-1 (PENTA 9PACTG 390) Study Team..

J Acquir Immune Defic Syndr. 2015 Sep 1;70(1):42-53. doi: 10.1097/QAI.0000000000000671.

20.

Changing Trends in Complications and Mortality Rates Among US Youth and Young Adults With HIV Infection in the Era of Combination Antiretroviral Therapy.

Mirani G, Williams PL, Chernoff M, Abzug MJ, Levin MJ, Seage GR 3rd, Oleske JM, Purswani MU, Hazra R, Traite S, Zimmer B, Van Dyke RB; IMPAACT P1074 Study Team..

Clin Infect Dis. 2015 Dec 15;61(12):1850-61. doi: 10.1093/cid/civ687.

Items per page

Supplemental Content

Loading ...
Support Center